These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 16365936

  • 21. Paget disease of bone: therapeutic options.
    Silverman SL.
    J Clin Rheumatol; 2008 Oct; 14(5):299-305. PubMed ID: 18838910
    [Abstract] [Full Text] [Related]

  • 22. Zoledronate treatment in active Paget's disease.
    Chung G, Keen RW.
    Ann Rheum Dis; 2003 Mar; 62(3):275-6. PubMed ID: 12594123
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Paget's disease of bone: presentation, extent and response to bisphosphonates.
    Wang LM, Au-Yeong ML, McKenna MJ.
    Ir Med J; 2002 Sep; 95(8):244, 246. PubMed ID: 12405502
    [Abstract] [Full Text] [Related]

  • 26. Strategies of treatment of Paget's disease with bisphosphonates.
    Papapoulos SE.
    Semin Arthritis Rheum; 1994 Feb; 23(4):265-6. PubMed ID: 8009248
    [No Abstract] [Full Text] [Related]

  • 27. Therapeutic strategy in Paget's disease of bone.
    Meunier PJ, Vignot E.
    Bone; 1995 Nov; 17(5 Suppl):489S-491S. PubMed ID: 8573424
    [Abstract] [Full Text] [Related]

  • 28. Paget's disease of bone: reduction of disease activity with oral risedronate.
    Hosking DJ, Eusebio RA, Chines AA.
    Bone; 1998 Jan; 22(1):51-5. PubMed ID: 9437513
    [Abstract] [Full Text] [Related]

  • 29. [Therapeutic effects of risedronate on Paget's disease of bone].
    Takata S.
    Clin Calcium; 2006 Sep; 16(9):1508-12. PubMed ID: 16951476
    [Abstract] [Full Text] [Related]

  • 30. Comparative effects of an antiviral drug, inosiplex, and diphosphonates in Paget's disease of bone.
    Kanis JA, Preston CJ, Beard DJ, Beneton M, Harris S, Russell RG.
    Bone; 1985 Sep; 6(2):69-72. PubMed ID: 2409999
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Unusual presentation of Paget's disease of bone.
    Sathyakumar S, Kapoor N, Hephzibah J, Paul TV.
    BMJ Case Rep; 2016 Mar 04; 2016():. PubMed ID: 26944376
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Efficacious management with aminobisphosphonate (APD) in Paget's disease of bone.
    Harinck HI, Bijvoet OL, Blanksma HJ, Dahlinghaus-Nienhuys PJ.
    Clin Orthop Relat Res; 1987 Apr 04; (217):79-98. PubMed ID: 2951049
    [Abstract] [Full Text] [Related]

  • 36. [Usefulness of ethane-hydroxy-diphosphonate in the treatment of Paget's disease].
    Morales Piga A, García Vadillo A, Rodríguez García A, Elena Ibáñez A, Castro Beiras JM, Rodríguez Torrás M.
    Rev Clin Esp; 1985 Oct 04; 177(6):273-7. PubMed ID: 3936134
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Use of the bisphosphonate space in treatment and retreatment of Paget's disease.
    Stone MD, Patel S, Hosking DJ.
    Semin Arthritis Rheum; 1994 Feb 04; 23(4):278. PubMed ID: 8009256
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.